Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study
Open Access
- 13 October 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 22 (2), 417-426
- https://doi.org/10.1007/s00520-013-1991-4
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Management of treatment-emergent peripheral neuropathy in multiple myelomaLeukemia, 2011
- Chemotherapy-induced neuropathic painCurrent Opinion in Supportive & Palliative Care, 2011
- Unmet supportive care needs, psychological well‐being and quality of life in patients living with multiple myeloma and their partnersPsycho‐Oncology, 2010
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple MyelomaThe New England Journal of Medicine, 2008
- Improved survival in multiple myeloma and the impact of novel therapiesBlood, 2008
- Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North AmericaThe New England Journal of Medicine, 2007
- Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple MyelomaThe New England Journal of Medicine, 2007
- An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myelomaEuropean Journal of Cancer, 2007
- Bortezomib or High-Dose Dexamethasone for Relapsed Multiple MyelomaThe New England Journal of Medicine, 2005
- Health-related Quality of Life and Patients' Perceptions in Interferon-treated Multiple Myeloma PatientsActa Oncologica, 2000